Table 1.
Gene mutated | Change in function | Vertebrate homolog | Reason chosen | Reference |
---|---|---|---|---|
gsa-1 | Gain | Gαs | Reduced lethargus quiescence; resistant to isoflurane | (Saifee et al., 2011; Schwarz and Bringmann, 2013) |
acy-1 | Gain | Adenylate cyclase | Reduced lethargus quiescence | (Iwanir et al., 2013) |
pde-4 | Loss | PDE4 | Reduced lethargus quiescence | (Singh et al., 2014) |
kin-2 | Loss | PKA regulatory subunit | Reduced lethargus quiescence; resistant to isoflurane | (Saifee et al., 2011; Belfer et al., 2013) |
goa-1 | DN | Gαi/o | Reduced lethargus quiescence | (Singh et al., 2014) |
goa-1 | Loss | Gαi/o | Resistant to halothane | (van Swinderen et al., 2001) |
egl-30 | Gain | Gαq | Reduced lethargus quiescence; resistant to halothane | (Hawasli et al., 2004; Schwarz and Bringmann, 2013) |
eat-16 | Loss | Gαq RGS | Resistant to halothane and isoflurane | (van Swinderen et al., 2001) |
dgk-1 | Loss | DGK-θ | Resistant to halothane | (van Swinderen et al., 2002) |
gpa-12 | Loss | Gα12 | Activation inhibits feeding | (van der Linden et al., 2003) |
tpa-1 | Loss | PKCδ | Suppresses effects of gpa-12 activation | (van der Linden et al., 2003) |
eat-6 | Loss | Na+/K+ ATPase | Depolarized pharyngeal muscle | (Davis et al., 1995) |
egl-19 | Gain | L-type Ca2+ channel | Prolonged pharyngeal action potential | (Lee et al., 1997) |
tom-1 | Loss | Tomosyn | Increased neurotransmission | (Dybbs et al., 2005) |
slo-1 | Loss | BK channel | Increased neurotransmission; resistant to halothane | (Wang et al., 2001; Hawasli et al., 2004) |
unc-77 | Gain | NALCN channel | Resistant to halothane | (Humphrey et al., 2007) |
unc-64 | Neomorph | Syntaxin | Resistant to halothane and isoflurane | (van Swinderen et al., 1999) |
unc-7 | Loss | Innexin | Resistant to halothane | (Morgan et al., 1990) |
tbh-1 | Loss | Tyramine β-hydroxylase | Opposes 5-HT response | (Wragg et al., 2007) |
egl-4 | Loss | PKG | Reduced lethargus quiescence | (Raizen et al., 2008) |
DN, Dominant-negative.